The global sales of vascular access catheters are estimated to be worth USD 3.54 billion in 2025 and anticipated to reach a value of USD 6.17 billion by 2035. Sales are projected to rise at a CAGR of ...

In a clinical pilot study, researchers from the Massachusetts Institute of Technology (MIT) and Massachusetts General ...

The global sales of central venous catheter is estimated to be worth USD 2.9 billion in 2024 and anticipated to reach a value ...

the Surfacer Inside-Out Access Catheter System uses a novel approach to help restore and preserve access in patients experiencing central venous obstructions A traditional treatment for patients ...

Net Revenue of $39.1mm; Adjusted EBITDA of $23.6mm ‒ Conference Call Scheduled for Today at 8:30 a.m. Eastern Time BERKELEY HEIGHTS, NJ., May 06, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), ...

Alternating lumens or splitting doses for intravenous antibiotic administration in patients with multilumen catheters suspected of CRBSI is recommended. For CRBSI occurring in short-term CVCs ...

Its incidence in the general population is 0.5%. In cardiac surgery patients, it is suspected when using the left subclavian vein or left internal jugular vein for central venous catheter or ...

CVC = Central venous catheter; SBP = Systolic blood pressure Adapted with permission from [7,11,12]. Jean-Luc Pagani and Philippe Eggimann, Department of Adult Intensive Care Medicine & Burn ...